Ocuphire Pharma, INC. (IRD) — DEF 14A Filings
All DEF 14A filings from Ocuphire Pharma, INC.. Browse 1 Proxy Statement reports with AI-powered summaries and risk analysis.
DEF 14A Filings (1)
-
Ocuphire Pharma Schedules 2024 Annual Meeting of Stockholders for June 11
— Apr 29, 2024 Risk: low
Ocuphire Pharma, Inc. (IRD) filed a Proxy Statement (DEF 14A) with the SEC on April 29, 2024. Ocuphire Pharma, Inc. will hold its 2024 Annual Meeting of Stockho
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX